Skip to Content

BlackRock LifePath® Dyn 2055 Investor A LPVAX

Analyst rating as of

Morningstar’s Analysis

Will LPVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

BlackRock's firmwide resources power this series.

Senior Analyst


| |

The BlackRock LifePath Dynamic target-date series benefits from its combination of a seasoned asset-allocation team, strong underlying managers, and a thoughtful approach to investing tactically. The series’ relatively average fees continue to be its biggest headwind. Its cheapest share class continues to earn a Morningstar Analyst Rating of Bronze, but its more expensive share classes are rated Neutral.

Unlock our full analysis with Morningstar Premium